R1 RCM unveils 2023 outlook

R1 RCM reaffirmed its 2022 guidance and unveiled its 2023 outlook in a Jan. 5 news release. 

2022 full-year guidance:

  • Revenue of $1.79 billion to $1.8 billion
  • GAAP operating loss of $8 million to $13 million
  • Adjusted EBITDA of $420 million to $425 million

2023 expectations:

  • Revenue of $2.28 billion to $2.33 billion
  • GAAP operating income of $115 million to $140 million
  • Adjusted EBITDA of $595 million to $630 million

"As we head into 2023, we are focused on executing our strategic plan, including advancing our technology investments and driving our best-in-class commercial engine to deliver value for our customers and team members," CEO Lee Rivas said in the release. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like